Will Slew of Patent Bills Lower Drug Prices?

Legislation is targeting a wide range of patent practices, from product hopping to patent infringement settlements and inter partes review.

Patents concept image with business icons and copyspace - Illustration
Congress has introduced a flurry of bills targeting a range of patent practices.

Concern about drug prices are one of the last issues of bipartisan agreement these days, so it should not come as a surprise that the flurry of activity on the topic this year might threaten even the foundation of the pharmaceutical industry's business model: patents.

Members of the House and Senate have introduced a flurry of bills aiming to change how patents are used to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet